Novavax
NVAX · NASDAQ
Bulios Fair Price
$12.8
20.8% upside
Trenutna cena
$10.6
Po podatkih Bulios Fair Price je delnica NVAX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Novavax (NVAX) is a biotechnology company focused on developing innovative vaccine technologies. Their main goal is to provide effective and safe vaccinations against infectious diseases. Currently, Novavax is dedicated to the development of a vaccine for respiratory viruses, including COVID-19. Novavax stock is suitable for investors who closely follow the biotechnology industry and seek opportunities in the healthcare sector. Add Novavax stock to your watchlist on Bulios and stay informed about the latest developments and news regarding this innovative biotech company.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
John Charles Jacobs
Employees
749
Headquarters
Gaithersburg
Prihajajoči dogodki
Earnings
Upcoming earnings report